Teleflex Incorporated (TFX) Stock
TFX Key Statistics
About Teleflex Incorporated
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
CEO: Jason Weidman. Company website
TFX — Frequently Asked Questions
What is the TFX stock price today?
Teleflex Incorporated (TFX) trades at $156.33, up 0.66% on the day, as of Nov 12, 2026 09:30 UTC.
What is Teleflex Incorporated's market cap?
Teleflex Incorporated has a market capitalisation of $6.62B, calculated from the live TFX share price and shares outstanding.
What is the P/E ratio of TFX?
TFX trades at a trailing P/E of 19.00, from earnings per share of $8.23 over the last twelve months.
How much revenue does Teleflex Incorporated make?
Teleflex Incorporated generated revenue of $2.26B over the trailing twelve months, which puts the stock at 2.94 times sales.
Does TFX pay a dividend?
Yes. Teleflex Incorporated pays a dividend yielding 1.31% on the current share price.
What is the 52-week range for TFX?
TFX has traded between $100.18 and $156.67 over the past 52 weeks, and the last price is 0.2% below that high.
Is Teleflex Incorporated profitable?
Yes. Teleflex Incorporated keeps 13.51% of revenue as net income over the trailing twelve months.
What is the analyst price target for TFX?
Wall Street analysts rate TFX Buy, with an average price target of $158.17, 1.2% above the current price.
What sector is Teleflex Incorporated in?
Teleflex Incorporated is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.
Who is the CEO of Teleflex Incorporated?
Jason Weidman is the chief executive of Teleflex Incorporated, which employs 15,500 people.
Where can I track TFX in real time?
QFI Terminal shows TFX with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See TFX live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open TFX in Terminal See plans